1Q20 Balance Sheet Source: Public Company Filings Condensed Consolidated Balance Sheets - USD ($)
in Thousands Three Months Ended March 31, 2020 2019 Current Assets Cash and cash equivalents $ 1,842 $ 2,361 Restricted cash 25 173 Accounts receivable, net 6,121 5,824 Inventories, net 4,762
6,580 Prepaid expenses and other current assets 3,064 2,641 Total Current Assets 15,814 17,579 Noncurrent Assets Property and equipment, net 349 417 Right-of-use assets, operating lease 888 951 Intangible assets,
net 14,259 14,641 Goodwill 18,614 18,614 Other assets 1,027 1,330 Total Assets 50,951 53,532 Current Liabilities Short term loan, net 17,023 16,061 Line of credit, net 5,366 4,819 Other liabilities 209
500 Accounts payable 4,226 4,049 Accrued liabilities 4,570 4,721 Deferred revenue 330 311 Operating lease liability, current portion 352 345 Warrant derivative liability 841 2,220 Total Current Liabilities 32,917
33,026 Noncurrent Liabilities Notes payable, net 17,559 16,370 Operating lease liability 566 641 Total Noncurrent Liabilities 18,125 17,011 Total Liabilities 51,042 50,037 Redeemable Series E Convertible
StockRedeemable Series E preferred stock, $0.001 par value, 2,900,000 shares authorized, 1,387,378 shares issued and outstanding at March 31, 2020 and December 2019 10,566 10,566 Stockholders' Deficit Common stock, $0.001 par value,
88,000,000 shares authorized, 48,939,708 & 47,977,390 shares issued and outstanding at March 31, 2020 and December 31, 2019 49 48 Additional paid-in capital 200,051 194,150 Accumulated deficit (210,757) (201,269) Total
Stockholders' Deficit (10,657) (7,071) Total Liabilities, Redeemable Preferred Stock and Stockholders' Deficit 50,951 53,532 20